Direct Oral Anticoagulant Versus Warfarin After Left Atrial Appendage Closure With WATCHMAN: Updated Systematic Review and Meta-analysis
Authors:
- 21 July 2022
- journal article
- review article
- Published by Elsevier in Current Problems in Cardiology
- Vol. 47 (11) , 101335
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The NCDR Left Atrial Appendage Occlusion RegistryJACC, 2020
- A comparison of postprocedural anticoagulation in high‐risk patients undergoing WATCHMAN device implantationPacing and Clinical Electrophysiology, 2019
- 5-Year Outcomes After Left Atrial Appendage ClosureJACC, 2017
- Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registryEuroIntervention, 2017
- Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman deviceHeart Rhythm, 2017
- Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillationEP Europace, 2016
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile rangeBMC Medical Research Methodology, 2014
- Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin TherapyJACC, 2014
- Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trialThe Lancet, 2009
- Measuring inconsistency in meta-analysesBMJ, 2003